News from WCM

As director of the Center on Aging and Behavioral Research, Dr. Sara Czaja and her team are developing and testing innovative strategies and interventions that strive to keep older adults independent and engaged, socially, intellectually and even professionally.

A protein linked to both Alzheimer’s disease and a form of dementia increases the risk of cognitive impairment by reducing the number and responsiveness of blood vessels in the organ.

Cardiothoracic surgeon Dr. Erin Mills Iannacone aims not only to bring more women to her field, but to broaden NewYork-Presbyterian/Weill Cornell Medical Center’s surgical offerings.

By studying the powerful influences shaping how we die, Dr. Holly Prigerson is leading the effort of reimagine medical care at life’s end.

With a $7.5 million gift from the Friedman Family Foundation endowed by Stephen and Vice Chair Overseer Barbara Friedman, Weill Cornell Medicine has established an innovative cross-campus center dedicated to improving human health through research in the complex relationship between nutrition, inflammation and the development of disease.

Magnetic resonance imaging (MRI) may not be the best diagnostic choice universally for all men suspected of having prostate cancer, according to researchers at Weill Cornell Medicine and NewYork-Presbyterian.

First-year students in Weill Cornell Medical College’s Class of 2022 learned basic bleeding-control techniques during a Stop the Bleed training on Aug. 20.

From optimizing technology to prioritizing self-care, a prescription for the modern MD

Three distinguished Weill Cornell Medicine physician-scientists, Dr. Daniel Fitzgerald, Dr. Francis Lee and Dr. Virginia Pascual, have been inducted into the Association of American Physicians (AAP).

Levels of air pollution defined as “good” by the Environmental Protection Agency (EPA) may still harm the lungs of cigarette smokers, according to a new study conducted by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Awards, honors, prizes and achievements for the month of August.

The Class of 2022 adds to Weill Cornell Medicine’s diverse community. Its students hail from 18 countries and collectively speak 29 different languages. 

By sabotaging one of the tuberculosis bacterium’s defenses against antibiotics, Weill Cornell Medicine investigators may have found a way to accelerate treatment for the disease and possibly overcome growing resistance to existing therapies.  

Sensory stimulation during a critical period soon after birth is essential for establishing networks in the brain...

A new method for testing urinary tract infections yields more information than what conventional methods can offer, according to new research from investigators at Weill Cornell Medicine, Cornell’s Meinig School of Biomedical Engineering and NewYork-Presbyterian.

Conventional wisdom suggests that a high level of the protein prostate specific antigen (PSA) in men with prostate cancer means a poor prognosis. However, this may not always be the case in men with a particular subtype of prostate cancer, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researchers.

A minimally invasive procedure to replace the heart’s aortic valve has recently increased in popularity despite a lack of research on the new valves’ long-term durability, according to a new study from Weill Cornell Medicine.

Two years ago, in a remote region of Ecuador, ophthalmologist Dr. Elwin Schwartz, MD ’76, helped give a six-year-old girl the gift of sight. 

New molecules engineered by Weill Cornell Medicine researchers can enable rapid, direct “editing” of genes in a wide range of cell types, creating an array of research and therapeutic possibilities.

Treating early-stage lung cancers with drugs that unleash the immune system’s ability to attack malignant cells may hinder tumor growth and improve overall survival, according to new research by Weill Cornell Medicine and NewYork-Presbyterian investigators.